Image of the Day: Biomimetic Arteries

A newly engineered synthetic blood vessel offers a novel platform for developing drugs that treat high blood pressure.

Written byAmy Schleunes
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Researchers at Johns Hopkins University have created biomimetic microvessels that model the small muscular pulmonary arteries implicated in hypertension, according to a study published on March 25 in Science Advances. The authors report in the paper that these bioengineered arteries closely replicate the patterns and layering of human smooth muscle cells, extracellular matrix, and endothelial cells, improving upon animal models that are unable to recreate human physiology, structure, and function.

This potential testing model for hypertension drugs marks an “important step toward an in vitro platform for the study of vascular wall biology and arteriolar fluid mechanics in an anatomically correct and human tissue,” the researchers write in their conclusion, and may be applicable to other diseases, such as stroke and diabetes, that also involve pathologies at the microvascular level.

Q. Jin et al., “Biomimetic human small muscular pulmonary arteries,” Science Advances, doi:10.1126/sciadv.aaz2598, 2020.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • A former intern at The Scientist, Amy studied neurobiology at Cornell University and later earned her MFA in creative writing from the University of Iowa. She is a Los Angeles–based writer, editor, and communications strategist who collaborates on nonfiction books for Harper Collins and Houghton Mifflin Harcourt, and also teaches writing at Johns Hopkins University CTY. Her favorite projects involve sharing the insights of science and medicine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies